1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Nuclear Medicine Pilot Research Grant in Neuroendocrine Tumors (NETs) is sponsored by The Education and Research Foundation for Nuclear Medicine and Molecular Imaging (ERF) / Neuroendocrine Tumor Research Foundation (NETRF). This grant supports basic or clinical scientists in the early stages of their careers to conduct novel and innovative research in neuroendocrine tumors using nuclear medicine.
The goal is to generate preliminary data for future funding.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Opening Doors for Innovation in Nuclear Medicine Research - NETRF NETRF is excited to announce that applications are now open for the Nuclear Medicine Pilot Research Grant in Neuroendocrine Tumors (NETs), developed in partnership with The Education and Research Foundation for Nuclear Medicine and Molecular Imaging (ERF).
This funding opportunity is designed to help early-career scientists launch novel and innovative research projects that could lead to larger grants from other foundations, corporations, or government agencies. NETRF has funded this grant in collaboration with ERF since 2016; ERF reviews applications and selects the grantee. Applications are due August 31, 2025, by 5:00 p.
m. E. S.
T. The award will provide $100,000 over two years to support groundbreaking research in nuclear medicine for NETs. These funds can be used for salaries, research costs, and travel, with indirect expenses capped at 5%.
The selected investigator will also participate in the annual NETRF Research Symposium to share progress and findings, ensuring that this work benefits both the research community and patients.
We’re looking for basic or clinical scientists who: Hold an MD, PhD, or equivalent Are no more than five years post-training Have a full-time faculty (or equivalent) position at a non-profit, educational institution (outside of government agencies) Have not served as PI of a grant of more than $100,000 in a single year Demonstrate strong potential in nuclear medicine/molecular imaging research for NETs This grant is more than just financial support; it’s a launchpad for ideas that can change the future of NET care.
We aim to empower emerging scientists to pursue research that is innovative, original, and highly relevant to advancing nuclear medicine and molecular imaging. By fostering new talent and supporting high-impact projects, we are investing in discoveries that could lead to better diagnostics, treatments, and outcomes for people living with NETs. Ready to apply?
Complete applications (in PDF format) must include all required materials listed in the official guidelines and be emailed to info@mierf. org with the subject: NETS Research Grant Material Submission – LAST NAME . Learn full eligibility criteria and submission requirements.
Let’s push the boundaries of what’s possible in nuclear medicine for NETs—together. Prev Previous Rethinking Time and Biology in SI-NETs: Two New Studies Signal a New Era for Patients Next Expanding the Frontier of Neuroendocrine Tumor Imaging Next
According to the current listing, eligibility includes: Full-time position at an accredited U. S. university or medical school. U. S. citizen or permanent resident. No more than 10 years beyond doctoral degree or final year of postgraduate training, whichever is later. Confirm the full requirements in the official notice before applying.
The current listing shows $100,000 over two years. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was August 31, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Nuclear Medicine Pilot Research Grant in Neuroendocrine Tumors (NETs) is funded by The Education and Research Foundation for Nuclear Medicine and Molecular Imaging (ERF) / Neuroendocrine Tumor Research Foundation (NETRF). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The NIH Common Fund launched PRIMED-AI — Precision Medicine with AI: Integrating Imaging with Multimodal Data — as five coordinated funding opportunities (RFA-RM-27-011 through -015) that build a full pipeline from standards to clinic. Here is how the Playbook, Data-to-Model partnerships, Model-to-Clinic translation, Validation Center, and Logistics Center fit together, what each pays, who is eligible, and how to position before the October 2026 deadlines.
Read articleThe Gates Foundation committed at least $1 billion over two years to equitable AI alongside its 10th Goalkeepers Report — 40% education, 40% health, 10% agriculture, 10% digital infrastructure. Five days later, 60 organizations signed a five-year goal to reach 3.4 billion speakers of underrepresented languages. Here is how implementing nonprofits should read both.
Read articleThe Rural Utilities Service published the ARC Program on September 14, 2026. Same IRA Section 22004 authority that carried the $9.7 billion New ERA program, redirected to nuclear power supply and transmission efficiency. Letters of Interest open October 19 and close November 20.
Read article